psychedelics
08/27/2018
/
By Isabelle Z.
Clinical trial using magic mushrooms to treat depression gets go-ahead from FDA
The FDA has just granted U.S. approval to a life sciences startup in London to use the psychedelic ingredient found in magic mushrooms in a trial for treating depression. The startup, Compass Pathways, was launched just two years ago with the backing of Peter Thiel. The trial is a phase IIB study of various dosages […]
11/06/2017
/
By Michelle Simmons
“Magic mushrooms” may “reboot” the brain, relieving depression, according to new study
A new study finds that psilocybin, the active ingredient in “magic mushrooms,” may restart the brain and relieve depression, as reported by The Daily Mail. Researchers from the Imperial College London studied 20 participants with depression, all of whom were unresponsive to traditional antidepressants. They recruited participants from this group to take psilocybin; 19 out […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 PSYCHIATRY NEWS
Privacy Policy